Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Pharmaceuticals, has filed a US 510k application for CollaGUARD™, an advanced wound care product based on Innocoll's proprietary CollaRx™ membrane technology. More
Local business leader Paul Paolatto has been appointed Executive Director of the WORLDiscoveries technology transfer consortium set up to commercialize research at The University of Western Ontario, Robarts Research Institute and Lawson HRI More
Palau Pharma today announces that its partner, Iberhospitex S.A. ("IHT"), has received marketing approval from the Spanish Agency for Medicines and Medical devices for its ACTIVE® coronary stent. More
For pharma and biopharma business developers, the partnering event concept of "Continuous Business Development" has proven to be more productive than once-a-year partnering events. More
Cancer Research Technology Announce Collaboration with Hammersmith Hospital to develop High Intensity Focused Ultrasound for the Treatment of Cancer More
With deals increasing in terms of number and value, partnering at early stage development is now an integral component of pharmaceutical and biotech business strategy. Pharmalicensing has revised and updated its successful Early Stage report More
Except in clumsy moments, we rarely knock over the box of cereal or glass of orange juice as we reach for our morning cup of coffee. New research at The University of Western Ontario has helped unlock the mystery of how our brain allows us to avoid these More
Sinclair Pharma plc announces today that Decapinol®, its oral rinse for the treatment of gingivitis (gum inflammation), has received registration approval from the FDA as a prescription medical device. More
All rights reserved. Terms and Conditions | Contact us
